IL1B and renal cell carcinoma: According to a cell-based study [8], IL-1β, a crucial pro-inflammatory mediator, was reported to enhance metalloproteinase-dependent invasion of RCC cells through the activation of CCAAT enhancer–binding protein β (CEBPB).